360 N. PASTORIA AVENUE, SUNNYVALE, CA
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results
Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
Lucian Iancovici Resigns from the Board of Directors
News, Material Contracts
Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Free Writing Prospectus